The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abuse of Amphetamines and Structural Abnormalities in the Brain
Open accessAbstract
We review evidence that structural brain abnormalities are associated with abuse of amphetamines. A brief history of amphetamine use/abuse and evidence for toxicity is followed by a summary of findings from structural magnetic resonance imaging (MRI) studies of human subjects who had abused amphetamines and children who were exposed to amphetamines in utero. Evidence comes from studies that used a variety of techniques including manual tracing, pattern matching, voxel‐based, tensor‐based, or cortical thickness mapping, quantification of white matter signal hyperintensities, and diffusion tensor imaging. Ten studies compared controls to individuals who were exposed to methamphetamine. Three studies assessed individuals exposed to 3–4‐methylenedioxymethamphetamine (MDMA). Brain structural abnormalities were consistently reported in amphetamine abusers, as compared to control subjects. These included lower cortical gray matter volume and higher striatal volume than control subjects. These differences might reflect brain features that could predispose to substance dependence. High striatal volumes might also reflect compensation for toxicity in the dopamine‐rich basal ganglia. Prenatal exposure was associated with striatal volume that was below control values, suggesting that such compensation might not occur in utero.Several forms of white matter abnormality are also common and may involve gliosis. Many of the limitations and inconsistencies in the literature relate to techniques and cross‐sectional designs, which cannot infer causality. Potential confounding influences include effects of pre existing risk/protective factors, development, gender, severity of amphetamine abuse, abuse of other drugs, abstinence, and differences in lifestyle. Longitudinal designs in which multimodal datasets are acquired and are subjected to multivariate analyses would enhance our ability to provide general conclusions regarding the associations between amphetamine abuse and brain structure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
Navigation-related structural change in the hippocampi of taxi drivers
Maguire, E. A., Gadian, D. G., Johnsrude, I. S., Good, C. D., Ashburner, J., Frackowiak, R. S. J., & Frith, C. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070039597 · Cited by 3,225
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Song, S.-K., Sun, S.-W., Ju, W.-K., Lin, S.-J., Cross, A. H., & Neufeld, A. H. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.07.005 · Cited by 1,738
Decision making, the P3, and the locus coeruleus–norepinephrine system
Nieuwenhuis, S., Aston-Jones, G., & Cohen, J. D. (2005) · Psychological Bulletin · doi:10.1037/0033-2909.131.4.510 · Cited by 1,678
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
WITELSON, S. F. (1989) · Brain · doi:10.1093/brain/112.3.799 · Cited by 1,424
Rogers, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00091-8 · Cited by 1,101
(2009) · doi:10.1007/978-3-540-29678-2 · Cited by 900
Why Voxel-based morphometry should be used
Ashburner, J., & Friston, K. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0961 · Cited by 842
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760
Self-citationLoss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Benes, F. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060041004 · Cited by 744
Neuropsychology and neuropharmacology of P3a and P3b
Polich, J., & Criado, J. R. (2006) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.12.012 · Cited by 741
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
“Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images
Bookstein, F. L. (2001) · NeuroImage · doi:10.1006/nimg.2001.0770 · Cited by 664
Awad, I. A., Johnson, P. C., Spetzler, R. F., & Hodak, J. A. (1986) · Stroke · doi:10.1161/01.str.17.6.1090 · Cited by 572
Davatzikos, C. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.05.010 · Cited by 434
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Chang, L., Alicata, D., Ernst, T., & Volkow, N. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 430
Good, C. D., Scahill, R. I., Fox, N. C., Ashburner, J., Friston, K. J., Chan, D., Crum, W. R., Rossor, M. N., & Frackowiak, R. S. J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1202 · Cited by 410
Handbook of Neurotoxicology: Volume I
(2002) · Humana Press eBooks · doi:10.1007/978-1-59259-132-9 · Cited by 404
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 384
Self-citationDopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371
Voxel-Based Morphometric Analysis of Gray Matter in First Episode Schizophrenia
Kubicki, M. (2002) · NeuroImage · doi:10.1006/nimg.2002.1296 · Cited by 357
Harper, C., & Matsumoto, I. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.06.011 · Cited by 342
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P., Altshuler, L. L., Carter, M., Huang, D., Edwards, N., & Mintz, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 341
Self-citationMethamphetamine-induced neuronal damage: A possible role for free radicals
De Vito, M. J., & Wagner, G. C. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90130-5 · Cited by 270
Effects of Methamphetamine Dependence and HIV Infection on Cerebral Morphology
Jernigan, T. L., Gamst, A. C., Archibald, S. L., Fennema-Notestine, C., Mindt, M. R., Marcotte, T. L., Heaton, R. K., Ellis, R. J., & Grant, I. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1461 · Cited by 268
Baumann, M. H., Wang, X., & Rothman, R. B. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0322-6 · Cited by 265
Distributional assumptions in voxel-based morphometry
Salmond, C. H., Ashburner, J., Vargha-Khadem, F., Connelly, A., Gadian, D. G., & Friston, K. J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1153 · Cited by 256
Higher Cortical and Lower Subcortical Metabolism in Detoxified Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., Wong, C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.383 · Cited by 249
Ten simple rules for reporting voxel-based morphometry studies
Ridgway, G. R., Henley, S. M. D., Rohrer, J. D., Scahill, R. I., Warren, J. D., & Fox, N. C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.01.003 · Cited by 243
Chang, L., Smith, L. M., LoPresti, C., Yonekura, M. L., Kuo, J., Walot, I., & Ernst, T. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2004.06.004 · Cited by 243
Fumagalli, F., Gainetdinov, R. R., Wang, Y.-M., Valenzano, K. J., Miller, G. W., & Caron, M. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02424.1999 · Cited by 241
Partial Recovery of Brain Metabolism in Methamphetamine Abusers After Protracted Abstinence
Wang, G.-J., Volkow, N. D., Chang, L., Miller, E., Sedler, M., Hitzemann, R., Zhu, W., Logan, J., Ma, Y., & Fowler, J. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.242 · Cited by 241
Job, D. E., Whalley, H. C., McConnell, S., Glabus, M., Johnstone, E. C., & Lawrie, S. M. (2002) · NeuroImage · doi:10.1006/nimg.2002.1180 · Cited by 237
The relative contributions of ecstasy and cannabis to cognitive impairment
Croft, R. J., Mackay, A. J., Mills, A. T. D., & Gruzelier, J. G. H. (2001) · Psychopharmacology · doi:10.1007/s002130000591 · Cited by 225
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users
Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., & Miller, E. N. (2002) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00004-5 · Cited by 224
Voxel based versus region of interest analysis in diffusion tensor imaging of neurodevelopment
Snook, L., Plewes, C., & Beaulieu, C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.07.021 · Cited by 224
Voxel-based cortical thickness measurements in MRI
Hutton, C., De Vita, E., Ashburner, J., Deichmann, R., & Turner, R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.01.027 · Cited by 209
The vesicular monoamine transporter is not regulated by dopaminergic drug treatments
Borght, T. V., Kilbourn, M., Desmond, T., Kuhl, D., & Frey, K. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00594-3 · Cited by 205
Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response
Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E. N., & Ernst, T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 205
Altered states: the clinical effects of Ecstasy
Cole, J. C., & Sumnall, H. R. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00003-2 · Cited by 192
Albertson, D. N., Pruetz, B., Schmidt, C. J., Kuhn, D. M., Kapatos, G., & Bannon, M. J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02247.x · Cited by 190
Gouzoulis‐Mayfrank, E., & Daumann, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01314.x · Cited by 189
Combining structural and functional neuroimaging data for studying brain connectivity: A review
Rykhlevskaia, E., Gratton, G., & Fabiani, M. (2008) · Psychophysiology · doi:10.1111/j.1469-8986.2007.00621.x · Cited by 188
Benegal, V., Antony, G., Venkatasubramanian, G., & Jayakumar, P. N. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00043.x · Cited by 186
Keller, S. S., Mackay, C. E., Barrick, T. R., Wieshmann, U. C., Howard, M. A., & Roberts, N. (2002) · NeuroImage · doi:10.1006/nimg.2001.1072 · Cited by 186
Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia
Job, D. E., Whalley, H. C., McConnell, S., Glabus, M., Johnstone, E. C., & Lawrie, S. M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00158-0 · Cited by 177
Current Research on Methamphetamine-Induced Neurotoxicity: Animal Models of Monoamine Disruption
Kita, T., Wagner, G. C., & Nakashima, T. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.92.178 · Cited by 173
Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers
Kim, S. J., Lyoo, I. K., Hwang, J., Chung, A., Sung, Y. H., Kim, J. H., Kwon, D.-H., Chang, K. H., & Renshaw, P. F. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005699 · Cited by 171
Seiden, L. S., US Department of Health and Human Services; National Institute on Drug Abuse, & Sabol, K. E. (1996) · PsycEXTRA Dataset · doi:10.1037/e495672006-014 · Cited by 166
Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting
Song, D. D., & Haber, S. N. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05102.2000 · Cited by 163
Why is parkinsonism not a feature of human methamphetamine users?
Moszczyńska, A., Fitzmaurice, P. S., Ang, L. C., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., Aiken, S. S., Wickham, D. J., & Kish, S. J. (2004) · Brain · doi:10.1093/brain/awh046 · Cited by 163
Margolese, H. C., Chouinard, G., Kolivakis, T., Beauclair, L., & Miller, R. J. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000907 · Cited by 157
Bartzokis, G., Beckson, M., Lu, P. H., Edwards, N., Rapoport, R., Wiseman, E., & Bridge, P. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00052-9 · Cited by 155
Self-citationAmphetamine and its analogs : psychopharmacology, toxicology, and abuse
Cho, A. K., & Segal, D. S. (1994) · Academic Press eBooks · Cited by 146
Keller, S. S., Wilke, M., Wieshmann, U. C., Sluming, V., & Roberts, N. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.030 · Cited by 144
Stefański, R., Ladenheim, B., Lee, S. H., Cadet, J. L., & Goldberg, S. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00094-1 · Cited by 136
Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study
Cowan, R. L., Lyoo, I. K., Sung, S. M., Ahn, K. H., Kim, M. J., Hwang, J., Haga, E., Vimal, R. L. P., Lukas, S. E., & Renshaw, P. F. (2003) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.07.001 · Cited by 132
Segal, D. S., & Kuczenski, R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36838-7 · Cited by 131
Why do we need an Addiction supplement focused on methamphetamine?
Rawson, R. A., & Condon, T. P. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01781.x · Cited by 130
Harvey, D. C., Laćan, G., Tanious, S. P., & Melega, W. P. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02439-2 · Cited by 127
Lyoo, I. K., Streeter, C. C., Ahn, K. H., Lee, H. K., Pollack, M. H., Silveri, M. M., Nassar, L. E., Levin, J. M., Sarid‐Segal, O., Ciraulo, D. A., et al. (2004) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2004.04.001 · Cited by 123
Decreased frontal white-matter integrity in abstinent methamphetamine abusers
Chung, A., Lyoo, I. K., Kim, S. J., Hwang, J., Bae, S. C., Sung, Y. H., Sim, M., Song, I. C., Kim, J. H., Chang, K. H., et al. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007395 · Cited by 123
False positives in imaging genetics
Meyer‐Lindenberg, A., Nicodemus, K. K., Egan, M. F., Callicott, J. H., Mattay, V. S., & Weinberger, D. R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.058 · Cited by 118
Relationship among neuroimaging indices of cerebral health during normal aging
Kochunov, P., Thompson, P. M., Coyle, T. R., Lancaster, J. L., Kochunov, V., Royall, D. R., Mangin, J.-F., Rivière, D., & Fox, P. T. (2007) · Human Brain Mapping · doi:10.1002/hbm.20369 · Cited by 117
Decreased frontal white-matter volume in chronic substance abuse
Schlaepfer, T. E., Lancaster, E., Heidbreder, R., Strain, E. C., Kosel, M., Fisch, H., & Pearlson, G. D. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005705 · Cited by 114
Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment
Hogan, K. A., Staal, R. G. W., & Sonsalla, P. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742217.x · Cited by 107
Tata, D. Α., & Yamamoto, B. K. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01770.x · Cited by 105
Doblin, R. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399952 · Cited by 103
Frey, K. A., Kilbourn, M. R., & Robinson, T. E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01152-7 · Cited by 102
Bowyer, J. F., Gough, B., Slikker, W., Lipe, G. W., Newport, G. D., & Holson, R. R. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90284-z · Cited by 102
Brain maturation may be arrested in chronic cocaine addicts
Bartzokis, G., Beckson, M., Lu, P. H., Edwards, N., Bridge, P., & Mintz, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01315-x · Cited by 85
Self-citationIncreased white matter hyperintensities in male methamphetamine abusers
Bae, S. C., Lyoo, I. K., Sung, Y. H., Yoo, J., Chung, A., Yoon, S. J., Kim, D., Hwang, J., Kim, S. J., & Renshaw, P. F. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.016 · Cited by 85
de Win, M. M. L., Reneman, L., Jager, G., Vlieger, E.-J., Olabarriaga, S. D., Lavini, C., Bisschops, I., Majoie, C. B. L. M., Booij, J., den Heeten, G. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301225 · Cited by 84
Pharmacokinetics of SLI381 (ADDERALL XR), an Extended-Release Formulation of Adderall
McGough, J. J., Biederman, J., Greenhill, L. L., McCracken, J. T., Spencer, T. J., Posner, K., Wigal, S. B., GORNBEIN, J. A., Tulloch, S. J., & Swanson, J. M. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046850.56865.cb · Cited by 82
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse
Berman, S. M., Voytek, B., Mandelkern, M. A., Hassid, B. D., Isaacson, A. J., Monterosso, J. R., Miotto, K. A., Ling, W. W., & London, E. D. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002107 · Cited by 79
Self-citationBrain Mapping as a Tool to Study Neurodegeneration
Apostolova, L. G., & Thompson, P. M. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.009 · Cited by 76
Kilbourn, M. R., Frey, K. A., Borght, T. V., & Sherman, P. S. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00023-6 · Cited by 76
Bartzokis, G., Goldstein, I. B., Hance, D. B., Beckson, M., Shapiro, D., Lu, P. H., Edwards, N. J., Mintz, J., & Bridge, P. (1999) · PubMed · Cited by 74
Self-citationPsychostimulants and monoamine transporters: upsetting the balance
Elliott, J. M., & Beveridge, T. J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.005 · Cited by 72
Ricaurte, G. A., Mechan, A. O., Yuan, J. X., Hatzidimitriou, G., Xie, T., Mayne, A. H., & McCann, U. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087916 · Cited by 69
Attenuation of Cocaine and Methamphetamine Neurotoxicity by Coenzyme Q10
Klongpanichapak, S., Govitrapong, P., SHARMA, S. K., & Ebadi, M. (2006) · Neurochemical Research · doi:10.1007/s11064-005-9025-3 · Cited by 65
Fein, G., Landman, B. A., Tran, H. V., Barakos, J. A., Moon, K. L., Sclafani, V. D., & Shumway, R. H. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.10.054 · Cited by 63
Escubedo, E., Chipana, C., Pérez-Sánchez, M., Camarasa, J., & Pubill, D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089748 · Cited by 63
Check, E. (2004) · Nature · doi:10.1038/429126a · Cited by 62
Composite voxel-based analysis of volume and T2 relaxometry in temporal lobe epilepsy
Pell, G. S., Briellmann, R. S., Pardoe, H., Abbott, D. F., & Jackson, G. D. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.09.061 · Cited by 52
Achat‐Mendes, C., Anderson, K. L., & Itzhak, Y. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301119 · Cited by 50
Flaherty, L. T. (2013) · Routledge eBooks · doi:10.4324/9780203780589-9 · Cited by 49
Borcherding, B. G. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90029-8 · Cited by 48
Segal, D. S., & Kuczenski, R. T. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35066-9 · Cited by 48
Methamphetamine increases basal ganglia iron to levels observed in aging
Melega, W. P., Laćan, G., Harvey, D. C., & Way, B. M. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f0d4f4 · Cited by 47
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD
Advokat, C. D. (2007) · Journal of Attention Disorders · doi:10.1177/1087054706295605 · Cited by 47
Shape changes of the corpus callosum in abstinent methamphetamine users
Oh, J. S., Lyoo, I. K., Sung, Y. H., Hwang, J., Kim, J. H., Chung, A., Park, K. S., Kim, S. J., Renshaw, P. F., & Song, I. C. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.082 · Cited by 43
Hwang, J., Lyoo, I. K., Kim, S. J., Sung, Y. H., Bae, S. C., Cho, S.-N., Lee, H., Lee, D. S., & Renshaw, P. F. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.09.011 · Cited by 42
Methylphenidate and brain dopamine neurotoxicity
Yuan, J., McCann, U. D., & Ricaurte, G. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00771-3 · Cited by 41
Peters, G.-J., Kok, G., & Abraham, C. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02041.x · Cited by 41
Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum
Wu, P.-H., Shen, Y., Wang, Y.-H., Chi, C., & Yen, J. (2006) · Toxicology · doi:10.1016/j.tox.2006.06.015 · Cited by 40
Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making
Moeller, F. G., Steinberg, J. L., Lane, S. D., Buzby, M., Swann, A. C., Hasan, K. M., Kramer, L. A., & Narayana, P. A. (2007) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990701651564 · Cited by 39
Methamphetamine toxicity in mice is potentiated by exposure to loud music
Morton, A. J., Hickey, M. A., & Dean, L. C. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00026 · Cited by 39
Tardive dyskinesia and serum iron indices
Wirshing, D. A., Bartzokis, G., Pierre, J. M., Wirshing, W. C., Sun, A., Tishler, T. A., & Marder, S. R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00453-8 · Cited by 37
Self-citationMiller, D. B., O'Callaghan, J. P., & Ali, S. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05196.x · Cited by 36
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration
Double, K. L., Halliday, G. M., Henderson, J. M., Griffiths, F. M., Heinemann, T., Riederer, P. F., & Gerlach, M. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.006 · Cited by 36
Brain injury: prolonged induction of transcription factors
Pennypacker, K. R., Kassed, C. A., Eidizadeh, S., & O'Callaghan, J. P. (2000) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2000-1373 · Cited by 35
Teuchert‐Noodt, G., & Dawirs, R. R. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90181-a · Cited by 33
Sclafani, V. D., CLARK, H. W., Tolou‐Shams, M., Bloomer, C., SALAS, G. A., Norman, D. M., & Fein, G. (1998) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617798466049 · Cited by 33
Uchida, R. R., Del‐Ben, C. M., Araújo, D., Busatto, G. F., Duran, F., Crippa, J. A., & Graeff, F. G. (2008) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652008000100010 · Cited by 28
Taylor, S. F., Christensen, J. D., Holcomb, J. A., & Garver, D. L. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.06.004 · Cited by 27
Amphetamine‐induced movement disorder
Downes, M. A., & Whyte, I. M. (2005) · Emergency Medicine Australasia · doi:10.1111/j.1742-6723.2005.00735.x · Cited by 25
Silverstone, P. H., Asghar, S., O'Donnell, T., Ulrich, M., & Hanstock, C. C. (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029906 · Cited by 24
Morgan, M. J., Cascella, N. G., Stapleton, J. M., Phillips, R. L., Yung, B. C., Wong, D. F., Shaya, E. K., & London, E. D. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1712 · Cited by 19
Self-citationNTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
(2005) · PubMed · Cited by 19
Age-Related Changes in Frontal and Temporal Lobe Volumes in Men: A Magnetic Resonance Imaging Study
Bartzokis, G., Beckson, M., Lu, P. H., Nuechterlein, K. H., Edwards, N., & Mintz, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.461 · Cited by 14
Self-citationTutorial: A Critical Analysis of Voxel Based Morphometry (VBM).
Thacker, N. A. (2003) · Cited by 12
Isaac, G., Fredriksson, A., Danielsson, R., Eriksson, P., & Bergquist, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05236.x · Cited by 8
Effects of repeated administration of methamphetamine on P3-like potentials in rats
Takeuchi, S., Jodo, E., Suzuki, Y., Matsuki, T., Niwa, S., & Kayama, Y. (1999) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(99)00016-1 · Cited by 7
Cited by
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 498
Parkinson's Disease and the Environment
Ball, N., Teo, W.-P., Chandra, S., & Chapman, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00218 · Cited by 480
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24
Wierenga, L., Langen, M., Ambrosino, S., van Dijk, S., Oranje, B., & Durston, S. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.03.072 · Cited by 294
Potential adverse effects of amphetamine treatment on brain and behavior: a review
Berman, S. M., Kuczenski, R., McCracken, J. T., & London, E. D. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 261
Self-citation
Metadata
- Authors
- Berman, S., O'Neill, J., Fears, S., Bartzokis, G., & London, E. D.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2008-10
- Volume
- 1141
- Issue
- 1
- Pages
- 195-220
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1992861430
- Cited by
- 253
- References
- 121
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.